Background: Three-dimensional (3D) visualization systems, also known as heads-up systems, are now available for eye surgery and as with every new device there is need for a specific evaluation. Objectives: The aim of this study was to compare the efficiency, surgical comfort, and safety of a 3D visualization system to a standard binocular microscope (BM) in routine ophthalmologic procedures. Method: After a 4-week training period, a 3D visualization system (Ngenuity, Alcon®) available in one of the Robert Debré Hospital Ophthalmology Departments’ operating rooms was compared to a standard BM (OPMI LUMIRA 700, Zeiss®), in the process of a call for new device evaluation. From December 2017 to March 2018, 5 surgeons and their respective residents were asked to fill in a questionnaire for all procedures. Before the surgery, the surgeon recorded: (i) the type of surgery (cataract [PK], retinal detachment [RD], epiretinal membrane peeling [ERM], macular hole, vitreous haemorrhage [VH]), (ii) the type of visualization system chosen (3D or BM), and (iii) the estimated surgical risk (low, intermediate, or high grade). At the end of the procedure, the primary surgeon recorded the remaining parameters, including: (i) surgery duration, (ii) intraoperative complications, (iii) percentage of endoillumination for posterior segment surgeries, (iv) status of the operator (senior or resident) and operator switch if necessary (senior only, resident only, or resident with help of the senior), and rated: (i) the visual comfort (low, normal, excellent), (ii) the operative fluency (low, normal, excellent), (iii) backaches (none, low, moderate, important), and (iv) headaches (range from 0 to 10). Age and sex were collected retrospectively. The procedures performed with 3D and BM were subsequently compared using univariate (χ2, Fisher, Wilcoxon) and multivariate analysis (generalized linear model), allowing us to identify parameters independently associated with PK surgery duration. Results: A total of 102 valid questionnaires, relative to 73 PK and 29 vitreoretinal procedures, respectively, were analysed. As regards PK (3D, n = 25 vs. BM, n = 48), the mean age, sex ratio, surgical risk, intraoperative complications (1/25 vs. 4/48), visual comfort, backaches, and headaches were similar between the two systems. The use of 3D allowed faster PK surgeries (16.44 ± 4.36 vs. 21.44 ± 7.50 min; p = 0.007) and slightly enhanced the operative fluency. In vitreoretinal surgeries (3D, n = 14 vs. BM, n = 15), no obvious differences between the two visualization systems were observed, although the use of the 3D system was found to slightly decrease the operative fluency. Parameters independently associated with PK surgery duration were 3D visualization (β = –4.4 ± 1.4; p = 0.002), high preoperative surgical risk (β = 6.2 ± 2.4; p = 0.012), intraoperative complications (β = 8.7 ± 2.6; p = 0.001), and surgeon status (β = –4.4 ± 1.3; p = 0.001) in univariate and multivariate analysis. Conclusions: 3D visualization can be safely used in routine practice. It slightly improves the operative fluency, allowing faster PK surgery.

1.
Desai
N
,
Weinstock
RJ
. Surgical Techniques in Ophthalmology - Cataract Surgery. In:
New Dehli
IJ
, editor
.
Surgical Techniques in Ophthalmology
.
2010
. pp.
124
7
.
2.
Weinstock
RJ
.
Operate With Your Head Up
.
Volume 8
.
Cataract and Refractive Surgery Today
;
2011
. pp.
66
74
.
3.
Zhang
Z
,
Wang
L
,
Wei
Y
,
Fang
D
,
Fan
S
,
Zhang
S
.
The Preliminary Experiences with Three- Dimensional Heads-Up Display Viewing System for Vitreoretinal Surgery under Various Status
.
Current Eye Research. Taylor & Francis
.
2008
;
28
(
1
):
1
4
.
4.
Adam
MK
,
Thornton
S
,
Regillo
CD
,
Park
C
,
Ho
AC
,
Hsu
J
.
MINIMAL ENDOILLUMINATION LEVELS AND DISPLAY LUMINOUS EMITTANCE DURING THREE-DIMENSIONAL HEADS-UP VITREORETINAL SURGERY
.
Retina
.
2017
Sep
;
37
(
9
):
1746
9
.
[PubMed]
0275-004X
5.
Eckardt
C
,
Paulo
EB
.
HEADS-UP SURGERY FOR VITREORETINAL PROCEDURES
.
Retina
.
2016
Nov
;
36
(
1
):
137
47
.
[PubMed]
0275-004X
6.
Rizzo
S
,
Abbruzzese
G
,
Savastano
A
,
Giansanti
F
,
Caporossi
T
,
Barca
F
, et al.
3D SURGICAL VIEWING SYSTEM IN OPHTHALMOLOGY: Perceptions of the Surgical Team
.
Retina
.
2018
Apr
;
38
(
4
):
857
61
.
[PubMed]
0275-004X
7.
Romano
MR
,
Cennamo
G
,
Comune
C
,
Cennamo
M
,
Ferrara
M
,
Rombetto
L
, et al.
Evaluation of 3D heads-up vitrectomy: outcomes of psychometric skills testing and surgeon satisfaction
.
Eye (Lond)
.
2018
Jun
;
32
(
6
):
1093
8
.
[PubMed]
0950-222X
8.
Read
SP
,
Fortun
JA
.
Visualization of the retina and vitreous during vitreoretinal surgery: new technologies
.
Curr Opin Ophthalmol
.
2017
May
;
28
(
3
):
238
41
.
[PubMed]
1040-8738
9.
Talcott
KE
,
Adam
MK
,
Sioufi
K
,
Aderman
CM
,
Ali
FS
,
Mellen
PL
, et al.
Comparison of three-dimensional heads-up display surgical platform to standard operating microscope for macular surgery
.
Ophthalmol Retina
.
2019
Mar
;
3
(
3
):
244
51
.
[PubMed]
2468-7219
10.
Youssef
PN
,
Sheibani
N
,
Albert
DM
.
Retinal light toxicity. Nature Publishing Group
.
Nature Publishing Group
.
2010
Oct
;
25
(
1
):
1
14
.
11.
Charles
S
.
Illumination and phototoxicity issues in vitreoretinal surgery
.
Retina
.
2008
Jan
;
28
(
1
):
1
4
.
[PubMed]
0275-004X
12.
Kim
SH
,
Suh
YW
,
Song
JS
,
Park
JH
,
Kim
YY
,
Huh
K
, et al.
Clinical research on the ophthalmic factors affecting 3D asthenopia
.
J Pediatr Ophthalmol Strabismus
.
2012
Jul-Aug
;
49
(
4
):
248
53
.
[PubMed]
0191-3913
13.
Velasque
L
,
Dominguez
M
,
Fourmaux
E
,
Rosier
L
,
Seguy
C
,
Lapeyre
M
. HULC study – Heads-Up Learning Curve- Poster at the
2019
Paris EURETINA Congress
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.